Philadelphia, PA, United States of America

Ekaterina G Shatalova

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ekaterina G. Shatalova: Innovator in Cancer Treatment

Introduction

Ekaterina G. Shatalova is a prominent inventor based in Philadelphia, PA, specializing in innovative methods for cancer treatment. She has made significant contributions to the field of oncology, particularly in targeting specific pathways involved in cancer progression.

Latest Patents

Shatalova holds a patent for her work titled "Targeting of CYP1B1 in the treatment of head and neck cancer and lung cancer." This patent outlines methods for inhibiting the motility or proliferation of premalignant and malignant cells. Additionally, it provides techniques for treating malignancies of both the head and neck, as well as the lung. Her innovative approach aims to improve treatment outcomes for patients suffering from these aggressive forms of cancer. She has 1 patent to her name.

Career Highlights

Ekaterina G. Shatalova is affiliated with the Institute for Cancer Research, where she continues to advance her research in cancer therapies. Her work is characterized by a commitment to developing effective treatment strategies that target the underlying mechanisms of cancer.

Collaborations

Shatalova collaborates with esteemed colleagues, including Margie Clapper and Sibele Meireles, to further enhance the impact of her research. These collaborations foster a multidisciplinary approach to cancer treatment, combining expertise from various fields.

Conclusion

Ekaterina G. Shatalova is a dedicated inventor whose work in cancer treatment is paving the way for innovative therapies. Her contributions to the field are vital in the ongoing fight against cancer, and her research continues to inspire advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…